4 Stocks Taking Off In Pre Market Today

All three major U.S indices posted gains yesterday while the small-cap Russell 200 slipped 0.7% on the day.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Today, futures are down as traders anxiously await the Federal Reserve’s monetary policy review scheduled for release this afternoon. Fund Funds have been a crucial fuel supply for the recent rally, so any major policy changes could upset the market.

The most prominent Asian indices closed with mixed results overnight, with Japan’s Nikkei 225 falling 0.4. European markets are a sea of red, but it’s mostly fractional losses. The Eurozone Stoxx 600 is down 0.1%

Today’s featured earnings slate includes Dollar General (PANW) and Dollar Tree (). After the closing the bell, we’ll hear from cutting-edge cyberspace firm Okta (OKTA)..

These stocks are trading actively today.

Abbot Labs (ABL)

Abbot Labs received FDA approval for its COVID-19 Rapid Antigen test. The test about the size of a credit card and costs only $5, so so it’s practical and economic for smaller budgets. The low-cost tests could ultimate be used in school nurse homes.

Abbot is the most active S&{ 500 stock this morning and i’ts up 9.6%.

Clovis Airlines (CLVS)

The FDA approved Clovis’s FoundationOne (R) Liquid CDx, a liquid biopsy test for solid tumors with multiple companion diagnostics According to a company press release, “FoundationOne Liquid CDx is intended to be used as a companion diagnostic to identify patients who may benefit from treatment with specific FDA-approved targeted therapies, including Rubraca, the first PARP inhibitor approved for the treatment of BRCA1/2-mutant mCRPC..”

CLVS is trading actively and its one of the top NASDAQ stocks.

Pedeveco Corp. (PED)

Pedeveco announcd this morning that it is delivered an open letter to the trustee of bankrupt Sandridge Premian Trust (PER), its holders, and it’s operating to indicate its interest in acquiring the companbty and its underlying assets.

“The Trust is likely to be delisted from the New York Stock Exchange and be dissolved with its assets liquidated in less than a year,” Pedevco said in the letter.

PED rallied on the news and it’s currently up 61.7

Moxian Inc. (MOXC)

Beijing-based Moxian agreed to merger terms with Btab Group, a Delaware Corporation. MOXC is an offline to online social media services and internet media marketing services providers. The merger would produce a combined business with a valuation exceeding $400 million.

MOXC CEO: “We are very excited to partner with the Btab Group in a new era of growth for the Company, taking our combined experience in China and Australia to new markets in South-east Asia, with our pooled resources..”

Shares are up 56.6% on the news and MOXC ist he NASDAQ’s most active stock this morning

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular